Upstream Bio, Inc. UPB

Full chart Compare
Set alert

Price alert · UPB

All alert types
3.39 USD +0.04 (+1.19%)

At closeNov 3, 2026, 4:00 PM EST

3.41 +0.02 +0.59%

After hours · Nov 3, 4:00 PM ET

3.31 Day range 3.53
2.68 52-week range 33.68
YTD
-87.51%
1 year
-86.45%

Financial health

Altman Z-Score

8.04 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 4

Valuation

P/E -10.2×
FY 2022: -33.3×FY 2023: -21.0×FY 2024: -11.0×FY 2025: -10.2×
FY 2022 5y median -16.0× FY 2025
P/S 512×
FY 2022: 659×FY 2023: 336×FY 2024: 356×FY 2025: 512×
FY 2022 5y median 434× FY 2025
P/B 4.3×
FY 2022: -7.5×FY 2023: -6.5×FY 2024: 1.8×FY 2025: 4.3×
FY 2022 5y median -2.3× FY 2025
P/FCF -11.0×
FY 2022: -41.8×FY 2023: -21.0×FY 2024: -14.1×FY 2025: -11.0×
FY 2022 5y median -17.6× FY 2025
EV/EBITDA -9.5×
FY 2022: -32.8×FY 2023: -37.8×FY 2024: -8.3×FY 2025: -9.5×
FY 2022 5y median -21.1× FY 2025
EV/Sales 477×
FY 2022: 645×FY 2023: 325×FY 2024: 219×FY 2025: 477×
FY 2022 5y median 401× FY 2025
FCF Yield -9.1%
FY 2022: -2.4%FY 2023: -4.8%FY 2024: -7.1%FY 2025: -9.1%
FY 2022 5y median -5.9% FY 2025

Profitability

Gross Margin 100.0%
FY 2022: 100.0%FY 2023: 100.0%FY 2024: 100.0%FY 2025: 100.0%
FY 2022 5y median 100.0% FY 2025
Operating Margin -5618.8%
FY 2022: -1972.7%FY 2023: -1685.5%FY 2024: -3281.2%FY 2025: -5618.8%
FY 2022 5y median -2626.9% FY 2025
Net Margin -5026.0%
FY 2022: -1969.3%FY 2023: -862.9%FY 2024: -2650.0%FY 2025: -5026.0%
FY 2022 5y median -2309.7% FY 2025
ROE -42.2%
FY 2022: 22.5%FY 2023: 16.7%FY 2024: -13.4%FY 2025: -42.2%
FY 2022 5y median 1.7% FY 2025
ROIC -47.0%
FY 2022: -174.4%FY 2023: -36.2%FY 2024: -16.5%FY 2025: -47.0%
FY 2022 5y median -41.6% FY 2025
ROA -40.5%
FY 2022: -129.2%FY 2023: -17.5%FY 2024: -13.0%FY 2025: -40.5%
FY 2022 5y median -29.0% FY 2025

Growth (YoY)

Revenue 20.4%
FY 2022: 0.0%FY 2023: 96.4%FY 2024: -0.4%FY 2025: 20.4%
FY 2022 FY 2025
Operating Income -106.2%
FY 2022: 0.0%FY 2023: -67.8%FY 2024: -93.9%FY 2025: -106.2%
FY 2022 FY 2025
EPS (diluted) -78.5%
FY 2022: 0.0%FY 2023: -59.1%FY 2024: -41.9%FY 2025: -78.5%
FY 2022 FY 2025
Free Cash Flow -123.3%
FY 2022: 0.0%FY 2023: -99.3%FY 2024: -56.8%FY 2025: -123.3%
FY 2022 FY 2025

Financial Health

Current Ratio 26.2×
FY 2022: 3.8×FY 2023: 18.0×FY 2024: 44.6×FY 2025: 26.2×
FY 2022 5y median 22.1× FY 2025
Quick Ratio 26.2×
FY 2022: 3.8×FY 2023: 18.0×FY 2024: 44.6×FY 2025: 26.2×
FY 2022 5y median 22.1× FY 2025
Debt / Equity 0.0×
FY 2022: -0.0×FY 2023: -0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2022 5y median 0.0× FY 2025
Net Debt / EBITDA 0.7×
FY 2022: 0.7×FY 2023: 1.3×FY 2024: 5.2×FY 2025: 0.7×
FY 2022 5y median 1.0× FY 2025
Interest Coverage 0.0×
FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2022 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2022 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2022 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31